FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20190805E00209
1. Date of relevant event: 02/08/2019
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 00858
4. Name of listed corporation: Extrawell Pharmaceutical Holdings Limited 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 2,390,000,000
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Xie
(Other names) Yi
10. Name of director (Chinese): 謝毅 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1201The number of shares in which you are interested has reduced because:
you completed a sale of the shares
 
2201Interest of corporation controlled by you
 
 		 80,000,000  HKD      0.0910 
3101Cash
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position80,000,0003.35
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position00.00
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position0
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Ease Gold Investments LimitedP.O. Box 3321, Road Town, Tortola, British Virgin islands (British Virgin Islands)Xie Yi100.00N
Long position0
United Gene Group LtdMandar House, 3rd Floor, P.O. Box 2196, Johnson's Ghut, Tortola, VG1110, British Virgin Islands (British Virgin Islands)Ease Gold Investments Limited33.33N
Long position0
Biowindow Gene Development (Hong Kong) LimitedFlat A, 11/F., On Loong Commercial Building, 276-278 Lockhart Road, Wanchai, Hong Kong (Hong Kong)United Gene Group Ltd100.00N
Long position0
JNJ Investments LtdPortcullis Chambers, 4th Floor, Ellen Skelton Building, 3076 Sir Francis Drake Highway, Road Town, Tortola, VG1110, British Virgin Islands (British Virgin Islands)Biowindow Gene Development (Hong Kong) Limited100.00Y
Long position0
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information:
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 05/08/2019
(dd/mm/yyyy)